AI English summary of an SEC filing — figures as filed
Best Buy BBYThe company said it reported revenue of $9,672 million for the 13-week Q3 quarter ended November 1, 2025, compared with $9,445 million a year earlier. Enterprise comparable sales rose 2.7%. Domestic comparable sales rose 2.4%, and International comparable sales rose 6.3%.
Key points
AI summaryThe company said it reported revenue of $9,672 million for the 13-week Q3 quarter ended November 1, 2025, compared with $9,445 million a year earlier. Enterprise comparable sales rose 2.7%. Domestic comparable sales rose 2.4%, and International comparable sales rose 6.3%.
Best Buy said it recorded pre-tax, non-cash asset impairments of $192 million related to Best Buy Health in Q3, including $171 million of goodwill and intangible asset impairments and $21 million of long-lived asset impairments. Diluted EPS was $0.66, and adjusted diluted EPS was $1.40.
The company set its FY26 adjusted diluted EPS outlook at $6.25 to $6.35, compared with prior guidance of $6.15 to $6.30. It said its revenue outlook is $41.65 billion to $41.95 billion, compared with prior guidance of $41.1 billion to $41.9 billion. It said its adjusted operating income rate is unchanged at approximately 4.2%.
The company said it returned a total of $234 million to shareholders in Q3, including dividends of $199 million and share repurchases of $35 million. It expects to spend approximately $300 million on share repurchases during FY26. Its board of directors approved a regular quarterly cash dividend of $0.95 per common share.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 Revenue and Comparable Sales Growth
The company said it reported revenue of $9,672 million for the 13-week Q3 quarter ended November 1, 2025, compared with $9,445 million a year earlier. Enterprise comparable sales rose 2.7%. Domestic comparable sales rose 2.4%, and International comparable sales rose 6.3%.
Source · Based on the filing body and exhibits
Best Buy Health Impairments and GAAP and Adjusted EPS
Best Buy said it recorded pre-tax, non-cash asset impairments of $192 million related to Best Buy Health in Q3, including $171 million of goodwill and intangible asset impairments and $21 million of long-lived asset impairments. Diluted EPS was $0.66, and adjusted diluted EPS was $1.40.
Source · Based on the filing body and exhibits
FY26 Full-Year Guidance
The company set its FY26 adjusted diluted EPS outlook at $6.25 to $6.35, compared with prior guidance of $6.15 to $6.30. It said its revenue outlook is $41.65 billion to $41.95 billion, compared with prior guidance of $41.1 billion to $41.9 billion. It said its adjusted operating income rate is unchanged at approximately 4.2%.
Source · Based on the filing body and exhibits
Shareholder Returns and Quarterly Dividend
The company said it returned a total of $234 million to shareholders in Q3, including dividends of $199 million and share repurchases of $35 million. It expects to spend approximately $300 million on share repurchases during FY26. Its board of directors approved a regular quarterly cash dividend of $0.95 per common share.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…